Trial Profile
Phase II evaluation of pegylated interferon alfa-2b and temozolomide for the treatment of recurrent and progressive malignant gliomas
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2006
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Temozolomide (Primary)
- Indications Glioma
- Focus Therapeutic Use
- 31 Jul 2006 New trial record.